PUBLISHER: QYResearch | PRODUCT CODE: 1873575
PUBLISHER: QYResearch | PRODUCT CODE: 1873575
The global market for Corneal Transplant was estimated to be worth US$ 1538 million in 2024 and is forecast to a readjusted size of US$ 2287 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Corneal Transplant (keratoplasty) is a common transplantation procedure with a very high success rate. A scarred, severely painful, perforated, deformed or cloudy cornea (the clear layer in front of the iris and pupil) can be replaced with a clear, healthy cornea.
The donated cornea comes from a recently deceased person. Tissue matching is not routinely required because rejection is relatively rare and can usually be treated (see Complications of corneal transplantation). Transplantation is most likely to be successful when it is performed for diseases such as bullous keratopathy, keratoconus and certain corneal scars.
In a broad sense, corneal transplantation refers to replacing cloudy and diseased corneal tissue with foreign materials to achieve the purpose of restoring the patient's vision or controlling corneal diseases and beauty. Therefore, it includes allogeneic corneal transplantation, xenogeneic corneal transplantation, autologous corneal transplantation, tissue-engineered corneal transplantation and artificial corneal transplantation. Corneal transplantation usually refers to allogeneic corneal transplantation, which is to use normal corneal tissue of a foreign body to replace cloudy or diseased corneal tissue to restore vision or control corneal lesions. It is the one with the highest success rate among allogeneic organ transplants and one of the important eye restoration surgeries. The scope of this report is the various expenses incurred during corneal transplantation, including surgical expenses, consumables, cornea, anesthetic drugs, and various disposal costs during the treatment process.
Aging populations in developed and emerging economies lead to higher rates of corneal degeneration and diseases.
Age-related corneal endothelial failure (Fuchs' dystrophy) is one of the common indications for endothelial keratoplasty.
Advancements in Surgical Techniques
Minimally invasive techniques like DALK, DSEK, and DMEK offer faster recovery, better visual outcomes, and lower rejection rates compared to traditional PK.
The adoption of femtosecond lasers for precise cuts and better graft alignment has improved surgical success rates.
Expansion of Eye Banks and Donor Programs
Improved awareness campaigns and government initiatives have increased corneal tissue donations in many countries.
Technological progress in cornea preservation (e.g., hypothermic storage, organ culture) extends tissue shelf-life and facilitates international tissue exchange.
Increasing Healthcare Expenditure & Insurance Coverage
Rising disposable income, better access to healthcare services, and broader insurance coverage in developing economies boost the affordability of advanced eye surgeries.
Non-profit organizations and international collaborations provide support for surgeries in low-resource settings.
Innovation in Artificial Corneas (Keratoprostheses)
For patients unsuitable for traditional donor grafts or repeat graft failure, keratoprostheses (e.g., Boston KPro) offer hope.
Advances in biocompatible materials and design improve long-term outcomes for severe cases.
This report aims to provide a comprehensive presentation of the global market for Corneal Transplant, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Corneal Transplant by region & country, by Type, and by Application.
The Corneal Transplant market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corneal Transplant.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Corneal Transplant company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Corneal Transplant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Corneal Transplant in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.